Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Q1 Revenues Surge

NEW YORK, May 2 – Pyrosequencing of Uppsala, Sweden said Wednesday its first quarter revenues jumped six-fold to $1.9 million, compared with $300,000 in the year-ago quarter.

The SNP company linked revenue increases to 17 new sales of their PSQ 96 System during the quarter, compared to five instruments in the same quarter in 2000. Additionally, Pyrosequencing reported a rise in an installed base of 80 systems for applied genetic analysis worldwide.

The company’s expenses rose to $5.1 million from $2.7 million for the first quarter of 2000.

First-quarter net loss was $2.23 million, or 6 cents per share, compared with $2.37 million, or 9 cents a share, in the year-ago period.

As of the end of March, the company had $73.4 million in cash, cash equivalents, and investments in high-grade debt securities, including investments with maturity dates exceeding 12 months.

"We are off to a running start this year,” Pyrosequencing CEO Erik Wallden said in a statement. In addition to the sale of PSQ 96 Systems, Wallden also noted that the company signed a first customer to a new high-throughput SNP analysis program and introduced new software applications and reagent kits for sequence analysis.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.